Mark C. Petrie
Expertise in
17
conditions

Mark C. Petrie

126 University Place, G12 8TA, 
Glasgow, SCT, GB 
Expertise in
17
conditions
126 University Place, G12 8TA, 
Glasgow, SCT, GB 

Overview

Mark Petrie practices practicing medicine in Glasgow, United Kingdom.

Mr. Petrie is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Heart Failure, Peripartum Cardiomyopathy, Heart Failure with Preserved Ejection Fraction (HFpEF), Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

He is actively involved in clinical research, co-authoring 462 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

126 University Place, G12 8TA, Glasgow, SCT, United Kingdom
Other Locations
Western Infirmary
Glasgow, SCT, United Kingdom
Agamemnon Street, Clydebank, SCT, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase IV, Registry-based, Randomised, Controlled, Open-label Trial Investigating the Potential for Patiromer-facilitated Use of Higher Doses of MRAs in Addition to Standard Care to Improve Congestion, Well-being, Morbidity and Mortality
A Phase IV, Registry-based, Randomised, Controlled, Open-label Trial Investigating the Potential for Patiromer-facilitated Use of Higher Doses of MRAs in Addition to Standard Care to Improve Congestion, Well-being, Morbidity and Mortality
Enrollment Status: Terminated
Publish Date: March 04, 2025
Intervention Type: Drug
Study Drug: Patiromer
Study Phase: Phase 4
Studies of Empagliflozin and Its Cardiovascular, Renal and Metabolic Effects in Patients With Diabetes Mellitus (or Pre-diabetes) and Heart Failure (SUGAR-DM-HF)
Studies of Empagliflozin and Its Cardiovascular, Renal and Metabolic Effects in Patients With Diabetes Mellitus (or Pre-diabetes) and Heart Failure (SUGAR-DM-HF)
Enrollment Status: Completed
Publish Date: September 18, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

462 Total Publications

Prevention of heart failure.
Prevention of heart failure.
Journal: European heart journal
Published: May 30, 2026

Frequently Asked Questions about Mark C. Petrie

Is Mark C. Petrie a top-rated expert for Heart Failure?

MediFind is an objective health platform that identifies experts based on real-world data. Mark C. Petrie is classified as an Elite expert for Heart Failure, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mark C. Petrie participate in research or clinical trials?

Yes. Mark C. Petrie has published 462 articles and abstracts on conditions like Heart Failure. You can view a list of Mark C. Petrie's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Petrie's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 39 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile